Clinical Trial Update: Ologen (OculusGen)-Glaucoma MMC Control Trial in India [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for Ologen (OculusGen) evaluating glaucoma treatment with MMC control in India; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Ologen

Snippet

Sponsor: Pro Top & Mediking Company Limited | Conditions: Glaucoma | Phase 4 | Status: UNKNOWN